Advisory Alpha’s Axogen AXGN Stock Holding History

Advisory Alpha’s Portfolio AXGN Stock Details AXGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$286K	Sell	6,200 -3,000	-33%	-$121K	0.01%	484
2026 Q1	$305K	Hold	9,200	–	–	0.01%	451
2025 Q4	$301K	Buy	+9,200	New	+$226K	0.01%	420

Other funds holding AXGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Advisory Alpha's AXGN Position: Q2 2026 in Review

Advisory Alpha reduced its Axogen (AXGN) stake by 33% in Q2 2026, selling an estimated $121K and leaving 6,200 shares worth $286K. The position accounts for 0.01% of the portfolio, ranked #484.

Advisory Alpha first reported a position in AXGN in Q4 2025 and has held it in 3 quarters since. The position peaked at $305K in Q1 2026. 254 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.

Advisory Alpha held 6,200 shares of Axogen worth $286K as of Q2 2026.
Advisory Alpha sold 3,000 Axogen shares in Q2 2026, an estimated $121K.
Axogen made up 0.01% of Advisory Alpha's portfolio in Q2 2026, its #484 holding.
Advisory Alpha first reported a position in Axogen in Q4 2025 and has held it in 3 quarters since.
Advisory Alpha's Axogen position peaked at $305K in Q1 2026.
254 funds tracked by Wall St. Rank held Axogen as of Q2 2026.

Based on Advisory Alpha's 13F filing for Q2 2026, filed 11 Aug 2026.